1.43 - 1.45
1.18 - 2.36
880.0K / 1.73M (Avg.)
-18.00 | -0.08
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
124.44%
Revenue growth above 1.5x 0315.HK's 6.86%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
98.58%
Gross profit growth above 1.5x 0315.HK's 14.04%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
No Data
No Data available this quarter, please select a different quarter.
118.75%
Operating income growth at 50-75% of 0315.HK's 183.60%. Martin Whitman would doubt the firm’s ability to compete efficiently.
175.64%
Net income growth under 50% of 0315.HK's 591.90%. Michael Burry would suspect the firm is falling well behind a key competitor.
171.19%
EPS growth under 50% of 0315.HK's 646.32%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
176.82%
Diluted EPS growth under 50% of 0315.HK's 646.32%. Michael Burry would worry about an eroding competitive position or excessive dilution.
-12.41%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-10.92%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
52.24%
Dividend growth of 52.24% while 0315.HK is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
41.72%
OCF growth at 75-90% of 0315.HK's 53.37%. Bill Ackman would demand better working capital management or cost discipline.
30.53%
FCF growth under 50% of 0315.HK's 143.64%. Michael Burry would suspect weaker operating efficiencies or heavier capex burdens.
23.39%
10Y revenue/share CAGR under 50% of 0315.HK's 257.13%. Michael Burry would suspect a lasting competitive disadvantage.
20.96%
5Y revenue/share CAGR similar to 0315.HK's 20.17%. Walter Schloss might see both companies benefiting from the same mid-term trends.
25.12%
3Y revenue/share CAGR above 1.5x 0315.HK's 7.19%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
101.11%
10Y OCF/share CAGR under 50% of 0315.HK's 625.79%. Michael Burry would worry about a persistent underperformance in cash creation.
144.88%
5Y OCF/share CAGR above 1.5x 0315.HK's 68.34%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
171.89%
3Y OCF/share CAGR above 1.5x 0315.HK's 50.61%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
735.19%
Net income/share CAGR above 1.5x 0315.HK's 483.52% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
299.95%
Positive 5Y CAGR while 0315.HK is negative. John Neff might view this as a strong mid-term relative advantage.
239.97%
3Y net income/share CAGR above 1.5x 0315.HK's 103.96%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-37.57%
Cut dividends over 10 years while 0315.HK stands at 0.00%. Joel Greenblatt suspects a weaker ability to return capital vs. the competitor.
-61.01%
Both lowered dividends mid-term. Martin Whitman might suspect broad sector constraints or strategic shifts from dividends.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.